Teverelix TFA
Phase 2 small_molecule active
Quick answer
Teverelix TFA for Advanced prostate cancer is a Phase 2 program (small_molecule) at Nordic Group B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nordic Group B.V.
- Indication
- Advanced prostate cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active